Symetis is the leading European developer of innovative, minimally invasive heart valve replacements. Symetis markets and develops safe and intuitive heart valve replacement systems for high-risk patients suffering from severe aortic stenosis. The companies products give physicians greater control during delicate surgical interventions, and result in excellent patient outcomes. The vision of Symetis is to be the leader in establishing minimally-invasive transcatheter heart valve implantation devices to treat valvular heart disease.